COVID-19 and Influenza A&B Dual Test
Introducing the first CTDA-approved COVID-19 and Influenza A&B Dual Test. A simple single swab lateral flow test for quick, accurate and easy diagnosis.COVID-19 & Influenza Dual Test
About SureScreen Diagnostics
Established in 1996
Revolutionised point-of-care market
Diagnostic products across the globe
Quality products at a fair price
We believe that prevention is better than cure, so our point of care devices allow conditions to be identified early, in many cases before symptoms present themselves. Our drug and alcohol testing devices quickly and accurately detect evidence of illicit or illegal drugs in a donor's sample.
Our COVID-19 rapid tests identify COVID-19 present in a swab sample and give a qualitative yes/no result within 15 minutes.
The tests are perfect for screening quickly at the patient side for the presence of COVID-19. The tests can be used as a companion to the antibody test to increase the window of detection.
For nearly 25 years, we've been providing bespoke solutions to organisations like yours. Our services cover drug awareness courses to educate and empower your colleagues and lab services so you can feel confident in your screening and the results.
With our extensive experience as an organisation, we are perfectly placed to consult on your current screening policies and advise on how to create policies when none are in place.
Drug Awareness Course
Drug Policy Review
Multiple Disciplines - Bespoke Service
Each client is different, it's why we offer a bespoke service tailored to fit that organisational need. During our time in business we've had the pleasure of working alongside 1000's of clients, across multiple sectors, a handful of which are below.